Zomedica Corp.
ZOMDF
$0.08
$0.00-2.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.59% | 35.37% | 32.63% | 15.69% | 13.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.59% | 35.37% | 32.63% | 15.69% | 13.59% |
| Cost of Revenue | 51.04% | 58.39% | 40.65% | 37.27% | 29.90% |
| Gross Profit | 29.47% | 24.44% | 29.24% | 7.43% | 6.97% |
| SG&A Expenses | -16.28% | -18.09% | -7.53% | -3.73% | -9.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.36% | -9.96% | -2.62% | 1.83% | -1.15% |
| Operating Income | 49.18% | 43.78% | 36.72% | 11.21% | 11.15% |
| Income Before Tax | 49.38% | 92.96% | 36.02% | 8.69% | 69.32% |
| Income Tax Expenses | 116.67% | 168.42% | 3.17% | 29.63% | 108.39% |
| Earnings from Continuing Operations | 49.11% | 92.89% | 37.03% | 8.60% | 69.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.11% | 92.89% | 37.03% | 8.60% | 69.09% |
| EBIT | 49.18% | 43.78% | 36.72% | 11.21% | 11.15% |
| EBITDA | 63.36% | 53.71% | 46.84% | 13.05% | 13.47% |
| EPS Basic | 49.33% | 92.93% | 36.99% | 8.82% | 69.26% |
| Normalized Basic EPS | 48.94% | 43.14% | 36.17% | 7.14% | 7.84% |
| EPS Diluted | 49.33% | 92.93% | 36.99% | 8.82% | 69.26% |
| Normalized Diluted EPS | 48.94% | 43.14% | 36.17% | 7.14% | 7.84% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |